Open AccessStructure-based drug designing and immunoinformatics approach for SARS-CoV-2
Author(s) -
Pritam Kumar Panda,
N. Arul Murugan,
Paritosh Patel,
Suresh K. Verma,
Wei Luo,
HorstGünter Rubahn,
Yogendra Kumar Mishra,
Mrutyunjay Suar,
Rajeev Ahuja
Publication year - 2020
Publication title -
science advances
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.928
H-Index - 146
ISSN - 2375-2548
DOI - 10.1126/sciadv.abb8097
Subject(s) - drug repositioning , protease , drug , repurposing , drug discovery , virtual screening , virology , computational biology , drug development , antiviral drug , covid-19 , biology , pharmacology , medicine , bioinformatics , enzyme , biochemistry , disease , pathology , infectious disease (medical specialty) , ecology
We report development of in-silico approaches for the identification of anti-coronaviral drugs against SARS-CoV-2.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom